Bank Of America Corp Xortx Therapeutics Inc. Transaction History

Bank Of America Corp

  • $1.12 Trillion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$0.73 - $10.71 $162 - $2,388
-223 Reduced 99.11%
2 $0
Q3 2022

Nov 14, 2022
BUY
$0.94 - $10.98 $209 - $2,448
223 Added 11150.0%
225 $0
Q4 2021

Feb 08, 2022
BUY
$1.8 - $5.84 $3 - $11
2 New
2 $0

About XORTX Therapeutics Inc.

XRTX Quotes by TradingView
  • Ticker XRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,389,700
  • Market Cap $25.2M
  • Description
  • XORTX Therapeutics Inc., a bio-pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic ki...
More about XRTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email